Patent Milestone Update

We’re pleased to share that another of our patent applications has received a Notice of Allowance from the U.S. Patent and Trademark Office. While this is not yet a granted patent, it is a significant milestone — it means the application has been examined and approved for issuance. In official terms: "Prosecution on the merits is closed."

The patent will be formally granted 4–6 weeks after we pay the issuance fee. During this interim window, we have the opportunity to file continuation patents on additional embodiments covered in the original application — a valuable strategic step in protecting our broader IP. For confidentiality and strategic reasons, it's best practice not to share full details until the patent is officially granted. I look forward to providing you with a more in-depth look soon.

What I can share now is that this particular patent is especially meaningful to me. It addresses how to strategically treat multiple tumors in critically ill patients — a complex and often underserved area. The LifeBridge device is the only tumor-treating field (TTF) technology built from the ground up to manage this type of advanced disease. This patent lays the foundation for how we navigate such treatment challenges.

All inventors involved in the LifeBridge project have assigned full ownership of their rights to LifeBridge. As a result, LifeBridge — and you, our investors — fully own all current and pending intellectual property.

Your investment is directly enabling this groundbreaking innovation. Thank you for being part of the journey.